Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| 1 |
NVIDIA
NVDA
|
+$2.25B |
| 2 |
Microsoft
MSFT
|
+$1.39B |
| 3 |
Amazon
AMZN
|
+$1.26B |
| 4 |
Apple
AAPL
|
+$1.18B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$505M |
Top Sells
| 1 |
SPLK
Splunk Inc
SPLK
|
+$373M |
| 2 |
Amgen
AMGN
|
+$198M |
| 3 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
+$180M |
| 4 |
IMGN
Immunogen Inc
IMGN
|
+$160M |
| 5 |
General Motors
GM
|
+$121M |
Sector Composition
| 1 | Technology | 29.5% |
| 2 | Financials | 12.9% |
| 3 | Healthcare | 12.22% |
| 4 | Consumer Discretionary | 10.6% |
| 5 | Industrials | 9.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3076
Cato Corp
CATO
$91.1M
| $2.22M | ﹤0.01% |
383,920
+11,064
| +3% | +$63.8K |
|
3077
Bioventus
BVS
$484M
| $2.21M | ﹤0.01% |
424,764
+17,320
| +4% | +$90.1K |
|
3078
Security National Financial
SNFCA
$237M
| $2.19M | ﹤0.01% |
305,286
+26,350
| +9% | +$189K |
|
|
MOND
3079
DELISTED
Mondee Holdings, Inc. Class A Common Stock
MOND
| $2.19M | ﹤0.01% |
947,403
+16,271
| +2% | +$37.6K |
|
|
GTHX
3080
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $2.19M | ﹤0.01% |
505,805
+45,030
| +10% | +$195K |
|
3081
Atossa Therapeutics
ATOS
$108M
| $2.18M | ﹤0.01% |
1,212,323
+97,399
| +9% | +$175K |
|
3082
Purple Innovation
PRPL
$114M
| $2.18M | ﹤0.01% |
1,252,706
+18,199
| +1% | +$31.7K |
|
3083
DHI Group
DHX
$141M
| $2.18M | ﹤0.01% |
853,084
+42,440
| +5% | +$108K |
|
3084
BigBear.ai
BBAI
$1.88B
| $2.17M | ﹤0.01% |
1,059,098
+272,061
| +35% | +$558K |
|
3085
Sagimet Biosciences
SGMT
$220M
| $2.17M | ﹤0.01% |
399,799
+279,023
| +231% | +$1.51M |
|
|
VOXX
3086
DELISTED
VOXX International Corporation Class A
VOXX
| $2.16M | ﹤0.01% |
264,306
+1,114
| +0.4% | +$9.09K |
|
3087
Aemetis
AMTX
$137M
| $2.16M | ﹤0.01% |
360,008
-142
| -0% | -$851 |
|
3088
Entravision Communication
EVC
$226M
| $2.16M | ﹤0.01% |
1,314,943
+9,728
| +0.7% | +$16K |
|
3089
Sportradar
SRAD
$8.98B
| $2.15M | ﹤0.01% |
185,111
+3,064
| +2% | +$35.7K |
|
3090
Comtech Telecommunications
CMTL
$69.1M
| $2.14M | ﹤0.01% |
623,880
+19,134
| +3% | +$65.6K |
|
3091
KLX Energy Services
KLXE
$31.4M
| $2.14M | ﹤0.01% |
276,458
+264
| +0.1% | +$2.04K |
|
3092
Century Therapeutics
IPSC
$43.3M
| $2.13M | ﹤0.01% |
510,591
+42,134
| +9% | +$176K |
|
3093
Spire Global
SPIR
$307M
| $2.13M | ﹤0.01% |
177,256
+16,480
| +10% | +$198K |
|
3094
Smith-Midland
SMID
$211M
| $2.12M | ﹤0.01% |
45,168
+899
| +2% | +$42.2K |
|
3095
Eastern Company
EML
$155M
| $2.09M | ﹤0.01% |
61,363
+2,778
| +5% | +$94.7K |
|
|
DNMR
3096
DELISTED
Danimer Scientific, Inc.
DNMR
| $2.08M | ﹤0.01% |
47,805
+893
| +2% | +$38.9K |
|
3097
AEON Biopharma
AEON
$9.08M
| $2.08M | ﹤0.01% |
2,494
+102
| +4% | +$85.2K |
|
|
SACH
3098
Sachem Capital Corp
SACH
$62M
| $2.08M | ﹤0.01% |
465,322
+15,817
| +4% | +$70.6K |
|
|
QIPT
3099
Quipt Home Medical
QIPT
$117M
| $2.07M | ﹤0.01% |
473,896
+22,985
| +5% | +$100K |
|
3100
Seer Inc
SEER
$115M
| $2.06M | ﹤0.01% |
1,084,560
+22,728
| +2% | +$43.2K |
|